Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
15.19
+0.04 (0.26%)
At close: Jul 23, 2024, 4:00 PM
15.31
+0.12 (0.79%)
After-hours: Jul 23, 2024, 4:08 PM EDT

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Net Income
-99.34-96.66-104.79-71.1-23.99-4.32
Upgrade
Depreciation & Amortization
1.621.671.661.390.010.01
Upgrade
Share-Based Compensation
17.5417.2618.8315.913.110
Upgrade
Other Operating Activities
-6.65-62.243.11-0.861.23
Upgrade
Operating Cash Flow
-86.83-83.73-82.07-50.69-19.87-3.08
Upgrade
Capital Expenditures
-0.140.01-0.36-1.58-0.060
Upgrade
Change in Investments
-62.24-4.8791.84-273.8600
Upgrade
Investing Cash Flow
-62.38-4.8591.48-275.44-0.060
Upgrade
Share Issuance / Repurchase
142.02133.420.481.39221.190
Upgrade
Debt Issued / Paid
00003.090
Upgrade
Other Financing Activities
----134.12-
Upgrade
Financing Cash Flow
142.02133.420.481.39358.40
Upgrade
Net Cash Flow
-7.244.849.89-324.74338.48-3.08
Upgrade
Free Cash Flow
-86.97-83.71-82.43-52.27-19.92-3.08
Upgrade
Free Cash Flow Per Share
-1.56-1.85-2.06-1.32-2.84-1.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).